Mattias Born, head of equities at Berenberg, is another who feels there has been a change in market sentiment, with a greater desire among investors to own assets which have visible earnings today, rather than stocks which are more about future potential.
But he is quite cautious on the outlook for the global economy and so is sticking with the more defensive equity stocks in areas such as pharmaceuticals.
Article continues after advert
david.thorpe@ft.com
Page 3 of 3
